Caring for Women With Abnormal Papanicolaou Tests During Pregnancy

Journal of Midwifery and Women's Health

Volumn 54, Issue 3, 2009, Pages 201-210

  Bond, Sharon ^a  

^a NONE

Author keywords

adenocarcinoma; adolescent; cervical cancer screening; cervical intraepithelial neoplasia; colposcopy; dysplasia; guidelines; pregnancy; squamous cell cancer

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; PAPANICOLAOU TEST; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; REMISSION; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PRENATAL DIAGNOSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 65349098849     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2009.01.004     Document Type: Article

References (48)

1. Jones W.B., Shingleton H.M., Russell A., Fremgen A.M., Clive R.E., Winchester D.P., et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 77 (1996) 1479-1488
2. Abu-Rustum N, Jones W. Cervical carcinoma in pregnancy: Assessing the diagnostic and therapeutic options. Available at: www.medscape.com/viewarticle/408861_print [Accessed February 1, 2009].
3. Method M., and Brost B. Management of cervical cancer in pregnancy. Semin Surg Oncol 16 (1999) 251-260
4. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
5. Schiffman M.H., and Brinton L.A. The epidemiology of cervical carcinogenesis. Cancer 76 10 Suppl (1995) 1888-1901
6. Janerich D.T., Hadjimichael O., Schwartz P.E., Lowell D.M., Meigs J.W., Merino M.J., et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 85 (1995) 791-794
7. Harlan L.C., Bernstein A.B., and Kessler L.G. Cervical cancer screening: Who is not screened and why?. Am J Public Health 81 (1991) 885-890
8. Tsui J., Saraiya M., Thompson T., Dey A., and Richardson L. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Womens Health 16 (2007) 1447-1457
9. Wright Jr. T.C., Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., and Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 11 (2007) 223-239
10. Wright T., Massad L., Dunton C., Spitzer M., Wilkinson E., and Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197 (2007) 346-355
11. Schiffman M., and Adrianza M.E. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 44 (2000) 726-742
12. National Cancer Institute Web site. ASCUS/LSIL triage study (ALTS) findings: Questions and answers. Available at: www.cancer.gov/cancertopics/factsheet/altsqa [Accessed January 3, 2009].
13. American Society for Colposcopy and Cervical Pathology. 2006 guidelines for the management of women with abnormal cervical cancer screening tests. Available at: www.asccp.org/about.shtml [Accessed July 31, 2008].
14. Bond S. New guidelines for Pap screening and management of results. J Midwifery Womens Health 49 (2004) 57-59
15. American College of Obstetricians and Gynecologists. Cervical cytology screening. Number 45, August 2003. Int J Gynaecol Obstet 83 (2003) 237-247
16. Hewitt M., Devesa S., and Breen N. Cervical cancer screening among U.S. women: Analyses of the 2000 National Health Interview Survey. Prev Med 39 (2004) 270-278
17. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., and Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis. Lancet 367 (2006) 489-498
18. Sadler L., Saftlas A., Wang W., Exeter M., Whittaker J., and McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 291 (2004) 2100-2106
19. Arbyn M., Bergeron C., Klinkhamer P., Martin-Hirsch P., Siebers A.G., and Bulten J. Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. Obstet Gynecol 111 (2008) 167-177
20. Orr Jr. J.W., Barrett J.M., Orr P.F., Holloway R.W., and Holimon J.L. The efficacy and safety of the cytobrush during pregnancy. Gynecol Oncol 44 (1992) 260-262
21. Jones B.A., and Davey D.D. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 124 (2000) 672-681
22. Rivlin M.E., Woodliff J.M., Bowlin R.B., Moore Jr. J.L., Martin R.W., Grossman III J.H., et al. Comparison of cytobrush and cotton swab for Papanicolaou smears in pregnancy. J Reprod Med 38 (1993) 147-150
23. Paraiso M.F., Brady K., Helmchen R., and Roat T.W. Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women. Obstet Gynecol 84 (1994) 539-543
24. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
25. Eitan R., and Abu-Rustum N.R. Management of cervical carcinoma diagnosed during pregnancy. Prim Care Update Ob Gyns 10 (2003) 196-200
26. Connolly T., and Evans A. Atypical Papanicolaou smear in pregnancy. Clin Med Res 3 (2005) 13-18
27. Dunn T.S., Bajaj J.E., Stamm C.A., and Beaty B. Management of the minimally abnormal Papanicolaou smear in pregnancy. J Low Genit Tract Dis 5 (2001) 133-137
28. Insinga R.P., Dasbach E.J., Elbasha E.H., Liaw K.L., and Barr E. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2 (2007) 1-10
29. Chan J., Monk B., Brewer C., Keefe K., Osann K., McMeekin S., et al. HPV infection and number of lifetime sexual partners are strong predictors for "natural" regression of CIN 2 and 3. Br J Cancer 89 (2003) 1062-1066
30. Melnikow J., Nuovo J., Willan A.R., Chan B.K., and Howell L.P. Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 92 4 Pt 2 (1998) 727-735
31. Yost N., Santoso J., McIntire D., and Iliya F. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and II lesions. Obstet Gynecol 93 (1999) 359-362
32. Trimble C.L., Piantadosi S., Gravitt P., Ronnett B., Pizer E., Elko A., et al. Spontaneous regression of high-grade cervical dysplasia: Effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 11 (2005) 4717-4723
33. Kaneshiro B., Acoba J., Holzman J., Wachi K., and Carney M. Effect of delivery route on natural history of cervical dysplasia. Am J Obstet Gynecol 192 (2005) 1452-1454
34. American College of Obstetricians and Gynecology. ACOG Practice Bulletin No. 99: Management of abnormal cervical cytology and histology. Obstet Gynecol 112 (2008) 1419-1444
35. American Society for Colposcopy and Cervical Pathology. Guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Available at: www.asccp.org/consensus.shtml [Accessed January 4, 2009].
36. Jain A.G., Higgins R.V., and Boyle M.J. Management of low-grade squamous intraepithelial lesions during pregnancy. Am J Obstet Gynecol 177 (1997) 298-302
37. Kaminski P.F., Lyon D.S., Sorosky J.I., Wheelock J.B., and Podczaski E.S. Significance of atypical cervical cytology in pregnancy. Am J Perinatol 9 (1992) 340-343
38. Arbyn M., Sasieni P., Meijer C.J., Clavel C., Koliopoulos G., and Dillner J. Clinical applications of HPV testing: A summary of meta-analyses. Vaccine 24 Suppl 3 (2006) S78-S89
39. Jeronimo J., and Schiffman M. Colposcopy at the crossroads. Am J Obstet Gynecol 195 (2006) 349-353
40. Tam K. Atypical glandular cells in cervical smear during pregnancy and postpartum period. Clin Med Res 3 (2005) 1-2
41. Lacour R., Garner E., Molpus K., Ashfaq R., and Schorge J. Management of cervical adenocarcinoma in situ during pregnancy. Am J Obstet Gynecol 192 (2005) 1449-1451
42. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., and Wilkinson E.J. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2002) 2120-2129
43. Guido R. Human papillomavirus and cervical disease in adolescents. Clin Obstet Gynecol 51 (2008) 290-305
44. Moscicki A.B., Shiboski S., Hills N.K., Powell K.J., Jay N., Hanson E.N., et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364 (2004) 1678-1683
45. Moscicki A.B., Ellenberg J.H., Crowley-Nowick P., Darragh T.M., Xu J., and Fahrat S. Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents. J Infect Dis 190 (2004) 1413-1421
46. Wright J.D., Davila R.M., Pinto K.R., Merritt D.F., Gibb R.K., Rader J.S., et al. Cervical dysplasia in adolescents. Obstet Gynecol 106 (2005) 115-120
47. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91 (1999) 226-236
48. Massad L.S., Evans C.T., Strickler H.D., Burk R.D., Watts D.H., Cashin L., et al. Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities. Obstet Gynecol 106 (2005) 525-532